Rizatriptan 10mg Oral Wafers
S761LEAFLET Maxalt Melt 20120803
PACKAGE LEAFLET: INFORMATION FOR USER MAXALT MELT 10mg ORAL WAFERS (rizatriptan benzoate)
Your medicine is known as Maxalt Melt 10mg Oral Wafers but will be referred to as Maxalt Melt throughout the following leaflet.
Read all of this leaflet carefully before you start taking this medicine.
- Keep this leaflet. You may need to read it again.
- If you have any further questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
- If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
In this leaflet:
1. What Maxalt Melt is and what it is used for
2. Before you take Maxalt Melt
3. How to take Maxalt Melt
4. Possible side effects
5. How to store Maxalt Melt
6. Further information
1. WHAT MAXALT MELT IS AND WHAT IT IS USED FOR?
Maxalt Melt belongs to a class of medicines called selective serotonin 5-HT1B/1D receptor agonists.
Maxalt Melt is used to treat the headache phase of the migraine attack in adults.
Treatment with Maxalt Melt:
Reduces swelling of blood vessels surrounding the brain. This swelling results in the headache pain of a migraine attack.
2. BEFORE YOU TAKE MAXALT MELT
Do not take Maxalt Melt if:
• you are allergic (hypersensitive) to rizatriptan benzoate or any of the other ingredients of Maxalt Melt
• you have moderately severe or severe high blood pressure, or mild high blood pressure that is not controlled by medication
• you have or have ever had heart problems including heart attack or pain on the chest (angina) or you have experienced heart disease related signs
• you have severe liver or severe kidney problems
• you have had a stroke (cerebrovascular accident CVA) or mini stroke (transient ischaemic attack TIA)
• you have blockage problems with your arteries (peripheral vascular disease)
• you are taking monoamine oxidase (MAO) inhibitors such as moclobemide, phenelzine, tranylcypromine, or pargyline (drugs against depression), or linezolid (an antibiotic), or if it has been less than two weeks since you stopped taking MAO inhibitors
• you are now taking ergotamine-type medications, such as ergotamine or dihydro-ergotamine to treat your migraine or methysergide to prevent a migraine attack
• you are taking any other drug in the same class, such as sumatriptan, naratriptan or zolmitriptan to treat your migraine. (See Taking with other medicines below).
If you are not sure if any of the above apply to you, talk to your
doctor or pharmacist before taking Maxalt Melt.
Take special care with Maxalt Melt if you:
Before you take Maxalt Melt, tell your doctor or pharmacist, if:
• you have any of the following risk factors for heart disease: high blood pressure, diabetes, you smoke or you are using nicotine substitution, your family has a history of heart disease, you are a man over 40 years of age, or you are a postmenopausal woman
• you have kidney or liver problems
• you have a particular problem with the way your heart beats (bundle branch block)
• you have or have had any allergies
• your headache is associated with dizziness, difficulty in walking, lack of co-ordination or weakness in the leg and arm
• you use herbal preparation containing St. John's wort
• you have had allergic reaction like swelling of the face, lips, tongue and/or throat which may cause difficulty breathing and/or swallowing (angioedema).
• you are taking selective serotonin reuptake inhibitors (SSRIs) such as sertraline, escitalopram oxalate, and fluoxetine or serotonin norepinephrine reuptake inhibitors (SNRIs) such as venlafaxine, and duloxetine for depression
• you have had short lived symptoms including chest pain and tightness.
If you take Maxalt Melt too often this may result in you getting a chronic headache. In such cases you should contact your doctor as you may have to stop taking Maxalt Melt.
Please tell your doctor or pharmacist about your symptoms. Your doctor will decide if you have migraine. You should take Maxalt Melt only for a migraine attack. Maxalt Melt should not be used to treat headaches that might be caused by other, more serious conditions. Please tell your doctor if you are taking or have recently taken or plan to take, any other medicines including medicines obtained without a prescription. This includes herbal medicines and those you normally take for a migraine. This is because Maxalt Melt can affect the way some medicines work. Also, other medicines can affect Maxalt Melt.
Taking with other medicines
Do not take Maxalt Melt:
• if you are already taking a 5-HT1B/1D agonist (sometimes referred to as ‘triptans'), such as sumatriptan, naratriptan or zolmitriptan.
• if you are taking a monoamine oxidase (MAO) inhibitor such as moclobemide, phenelzine, tranylcypromine, linezolid, or pargyline or if it has been less than two weeks since you stopped taking an MAO inhibitor.
• if you use ergotamine-type medications such as ergotamine or dihydro-ergotamine to treat your migraine
• if you use methysergide to prevent a migraine attack.
The above listed medicines when taken with Maxalt Melt may increase the risk of side effects.
You should wait at least 6 hours after taking Maxalt Melt before you take ergotamine-type medications such as ergotamine or dihydro-ergotamine or methysergide.
You should wait at least 24 hours after taking ergotamine-type medications before taking Maxalt Melt.
Ask your doctor for instructions and the risks about taking Maxalt Melt
• if you are taking propranolol (see section 3: How to take Maxalt Melt).
• if you are taking SSRIs such as sertraline, escitalopram oxalate, and fluoxetine or SNRIs such as venlafaxine, and duloxetine for depression.
Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.
Taking Maxalt Melt with food and drink:
Maxalt Melt can take longer to work if it is taken after food. Although it is better to take it on an empty stomach, you can still take it if you have eaten.
Pregnancy and breast-feeding
It is not known whether Maxalt Melt is harmful to an unborn baby when taken by a pregnant woman.
Talk to your doctor before taking this medicine if you are pregnant, planning to get pregnant or are breastfeeding. Breastfeeding should be avoided for 24 hours after treatment.
Ask your doctor or pharmacist for advice before taking any medicine.
Use in children
The use of Maxalt Melt oral lyophilisates in children under 18 years is not recommended.
Use in patients older than 65 years
There have been no full studies to look at how safe and effective Maxalt Melt is amongst patients older than 65 years.
Driving or using machines
You may feel sleepy or dizzy while taking Maxalt Melt. If this happens, do not drive or use any tools or machines.
Important information about some of the ingredients of Maxalt Melt
Phenylketonuric patients: Contains a source of phenylalanine. May be harmful for people with phenylketonuria. Each Maxalt Melt oral lyophilisate contains 3.75 mg of aspartame (which contains phenylalanine).
3. HOW TO TAKE MAXALT MELT
Maxalt Melt is used to treat migraine attacks. Take Maxalt Melt as soon as possible after your migraine headache has started. Do not use it to prevent an attack.
Always take Maxalt Melt exactly as your doctor has told you. You should check with your doctor or your pharmacist if you are not sure.
The usual dose is 10 mg.
If you are currently taking propranolol or have kidney or liver problems you should use the 5-mg dose of Maxalt. You should leave at least 2 hours between taking propranolol and Maxalt Melt up to a maximum of 2 doses in a 24-hour period.
If migraine returns within 24 hours
In some patients, migraine symptoms can return within a 24-hour period. If your migraine does return you can take an additional dose of Maxalt Melt. You should always wait at least 2 hours between doses.
If you do not respond to the first dose of Maxalt Melt during an attack, you should not take a second dose of Maxalt Melt for treatment of the same attack. It is still likely, however, that you will respond to Maxalt Melt during the next attack.
Do not take more than 2 doses of Maxalt Melt in a 24-hour period, (for example, do not take more than two 10-mg oral lyophilisates or more than two 10 mg or 5 mg tablets in a 24-hour period). You should always wait at least 2 hours between doses.
If your condition worsens, seek medical attention.
How to administer Maxalt Melt oral lyophilisates
- Maxalt (rizatriptan benzoate) is available as a 10 mg oral lyophilisate that dissolves in the mouth.
- Open the Maxalt Melt oral lyophilisate blister pack with dry hands.
- The oral lyophilisate should be placed on your tongue, where it dissolves and can be swallowed with the saliva.
- The oral lyophilisate can be used in situations in which liquids are not available, or to avoid the nausea and vomiting that may accompany the ingestion of tablets with liquids.
Maxalt is also available as a tablet to be taken with liquids.
If you take more Maxalt Melt than you should:
If you take more Maxalt Melt than you should, talk to your doctor or pharmacist straight away. Take the medicine pack with you.
Signs of overdosage can include dizziness, drowsiness, vomiting, fainting and slow heart rate.
If you have any further questions on the use of this product ask your doctor or pharmacist.
4. POSSIBLE SIDE EFFECTS
Like all medicines, Maxalt Melt can cause side effects, although not
everybody gets them. The following side effects may happen with
this medicine.
In adult studies, the most common side effects reported were
dizziness, sleepiness and tiredness.
Common (affects 1 to 10 users in 100)
• tingling (paraesthesia), headache, decreased sensitivity of skin (hypoaesthesia), decreased mental sharpness, tremor,
• fast or irregular heart beat (palpitation), very fast heartbeat (tachycardia),
• flushing (redness of the face lasting a short time), hot flushes, sweating,
• throat discomfort, difficulty breathing (dyspnoea),
• feeling sick (nausea), dry mouth, vomiting, diarrhoea,
• feeling of heaviness in parts of the body,
• pain in abdomen or chest,
• rash.
Uncommon (affects 1 to 10 users in 1000)
• unsteadiness when walking (ataxia), dizziness (vertigo), blurred vision,
• confusion, insomnia, nervousness,
• high blood pressure (hypertension); thirst, indigestion (dyspepsia),
• itching and lumpy rash (hives), allergic reaction (hypersensitivity; swelling of face, lips, tongue and/or throat which may cause difficulty breathing and/or swallowing (angioedema),
• neck pain, feeling of tightness in parts of the body, stiffness, muscle weakness
Rare (affects 1 to 10 users in 10,000)
• bad taste in your mouth,
• fainting (syncope), a syndrome called “serotonin syndrome” that may cause side effects like coma, unstable blood pressure, extremely high body temperature, lack of muscle co-ordination, agitation, and hallucinations
• facial pain, wheezing
• sudden life-threatening allergic reaction (anaphylaxis), severe shedding of the skin with or without fever (toxic epidermal necrolysis),
• heart attack, spasm of blood vessels of the heart, stroke. They generally occur in patients with risk factors for heart and blood vessel disease (high blood pressure, diabetes, smoking, use of nicotine substitution, family history of heart disease or stroke, man over 40 years of age, post-menopausal women, particular problem with the way your heart beats [bundle branch block]).
Not known (frequency cannot be estimated from the available data):
• seizure (convulsions/fits),
• spasm of blood vessels of the extremities including coldness and numbness of the hands or feet,
• spasm of the blood vessels of the colon (large bowel), which can cause abdominal pain,
• muscle pain,
• changes in the rhythm or rate of the heartbeat (arrhythmia), slow heartbeat (bradycardia), abnormalities of the electrocardiogram (a test that records the electrical activity of your heart).
Tell your doctor right away if you have symptoms of allergic reactions, serotonin syndrome, heart attack or stroke.
In addition, tell your doctor if you experience any symptoms that suggest an allergic reaction (such as a rash or itching) after taking Maxalt Melt.
If any of the side effects get serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
5. HOW TO STORE MAXALT MELT
• KEEP OUT OF THE SIGHT AND REACH OF CHILDREN.
• Maxalt Melt should be not stored above 30°C.
• Do not remove the oral lyophilisate from its blister or the aluminium sachet until you are ready to take it.
• Keep the oral lyophilisate in the carrying case for protection.
• Do not put the oral lyophilisate into another container, as they might get mixed up.
• Do not use after the expiry date printed on the carton label or blister strip.
• If your doctor tells you to stop using the medicine, please take it back to the pharmacist for safe disposal. Only keep the medicine if your doctor tells you to.
• If the medicine becomes discoloured or shows any other signs of deterioration, you should seek the advice of your pharmacist who will tell you what to do.
• Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose medicines no longer required. These measures will help to protect the environment.
6. FURTHER INFORMATION
What Maxalt Melt contains
Each lyophilisate contains 14.53mg rizatriptan benzoate equivalent to 10.00mg of rizatriptan
Maxalt Melt oral lyophilisate also contain the following inactive ingredients: gelatin, mannitol, glycine, aspartame (E951) and peppermint flavour.
What Maxalt Melt looks like and contents of the pack
Maxalt Melt is a white to off-white, round, peppermint flavoured oral lyophilisate embossed with a rounded square. Maxalt Melt is a freeze-dried oral lyophilisate which dissolves in the mouth.
Maxalt Melt is available in packs of 3 individually sealed oral lyophilisate.
Product Licence holder
Procured from within the EU and repackaged by the Product Licence holder: S&M Medical Ltd, Chemilines House,
Alperton Lane, Wembley, HA0 1DX.
Manufacturer
These products are manufactured by Catalent UK Swindon Zydis Ltd, Swindon, UK.
|POM | PL No: 19488/0761 Leaflet revision date: 03 August 2012
Maxalt is a registered trade mark of Merck & Co. Inc., USA.
Further information about migraine is available from the following organisations:
Migraine Action Association 4th Floor, 27 East Street Leicester LE1 6NB
Tel: 0116 275 8317 Fax: 0116 254 2023 and
The Migraine Trust
55-56 Russell Square
London
WC1B 4HP
Tel: 020 7631 6970
Fax: 020 7436 2886
Email: info@migrainetrust.org
Helpline: 020 7462 6601, Monday to Friday 10am - 5pm
S761 LEAFLET Maxalt Melt 20120803
S761 LEAFLET Rizatriptan 20120803
PACKAGE LEAFLET: INFORMATION FOR USER RIZATRIPTAN 10mg ORAL WAFERS (rizatriptan benzoate)
Your medicine is known as Rizatriptan 10mg Oral Wafers but will be referred to as Rizatriptan throughout the following leaflet.
Read all of this leaflet carefully before you start taking this medicine.
- Keep this leaflet. You may need to read it again.
- If you have any further questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
- If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
In this leaflet:
1. What Rizatriptan is and what it is used for
2. Before you take Rizatriptan
3. How to take Rizatriptan
4. Possible side effects
5. How to store Rizatriptan
6. Further information
1. WHAT RIZATRIPTAN IS AND WHAT IT IS USED FOR?
Rizatriptan belongs to a class of medicines called selective serotonin 5-HT1B/1D receptor agonists.
Rizatriptan is used to treat the headache phase of the migraine attack in adults.
Treatment with Rizatriptan:
Reduces swelling of blood vessels surrounding the brain. This swelling results in the headache pain of a migraine attack.
2. BEFORE YOU TAKE RIZATRIPTAN
Do not take Rizatriptan if:
• you are allergic (hypersensitive) to rizatriptan benzoate or any of the other ingredients of Rizatriptan
• you have moderately severe or severe high blood pressure, or mild high blood pressure that is not controlled by medication
• you have or have ever had heart problems including heart attack or pain on the chest (angina) or you have experienced heart disease related signs
• you have severe liver or severe kidney problems
• you have had a stroke (cerebrovascular accident CVA) or mini stroke (transient ischaemic attack TIA)
• you have blockage problems with your arteries (peripheral vascular disease)
• you are taking monoamine oxidase (MAO) inhibitors such as moclobemide, phenelzine, tranylcypromine, or pargyline (drugs against depression), or linezolid (an antibiotic), or if it has been less than two weeks since you stopped taking MAO inhibitors
• you are now taking ergotamine-type medications, such as ergotamine or dihydro-ergotamine to treat your migraine or methysergide to prevent a migraine attack
• you are taking any other drug in the same class, such as sumatriptan, naratriptan or zolmitriptan to treat your migraine. (See Taking with other medicines below).
If you are not sure if any of the above apply to you, talk to your
doctor or pharmacist before taking Rizatriptan.
Take special care with Rizatriptan if you:
Before you take Rizatriptan, tell your doctor or pharmacist, if:
• you have any of the following risk factors for heart disease: high blood pressure, diabetes, you smoke or you are using nicotine substitution, your family has a history of heart disease, you are a man over 40 years of age, or you are a postmenopausal woman
• you have kidney or liver problems
• you have a particular problem with the way your heart beats (bundle branch block)
• you have or have had any allergies
• your headache is associated with dizziness, difficulty in walking, lack of co-ordination or weakness in the leg and arm
• you use herbal preparation containing St. John's wort
• you have had allergic reaction like swelling of the face, lips, tongue and/or throat which may cause difficulty breathing and/or swallowing (angioedema).
• you are taking selective serotonin reuptake inhibitors (SSRIs) such as sertraline, escitalopram oxalate, and fluoxetine or serotonin norepinephrine reuptake inhibitors (SNRIs) such as venlafaxine, and duloxetine for depression.
• you have had short lived symptoms including chest pain and tightness.
If you take Rizatriptan too often this may result in you getting a chronic headache. In such cases you should contact your doctor as you may have to stop taking Rizatriptan.
Please tell your doctor or pharmacist about your symptoms. Your doctor will decide if you have migraine. You should take Rizatriptan only for a migraine attack. Rizatriptan should not be used to treat headaches that might be caused by other, more serious conditions. Please tell your doctor if you are taking or have recently taken or plan to take, any other medicines including medicines obtained without a prescription. This includes herbal medicines and those you normally take for a migraine. This is because Rizatriptan can affect the way some medicines work. Also, other medicines can affect Rizatriptan.
Taking with other medicines Do not take Rizatriptan:
• if you are already taking a 5-HT1B/1D agonist (sometimes referred to as ‘triptans'), such as sumatriptan, naratriptan or zolmitriptan.
• if you are taking a monoamine oxidase (MAO) inhibitor such as moclobemide, phenelzine, tranylcypromine, linezolid, or pargyline or if it has been less than two weeks since you stopped taking an MAO inhibitor.
• if you use ergotamine-type medications such as ergotamine or dihydro-ergotamine to treat your migraine
• if you use methysergide to prevent a migraine attack.
The above listed medicines when taken with Rizatriptan may increase the risk of side effects.
You should wait at least 6 hours after taking Rizatriptan before you take ergotamine-type medications such as ergotamine or dihydro-ergotamine or methysergide.
You should wait at least 24 hours after taking ergotamine-type medications before taking Rizatriptan.
Ask your doctor for instructions and the risks about taking Rizatriptan
• if you are taking propranolol (see section 3: How to take Rizatriptan).
• if you are taking SSRIs such as sertraline, escitalopram oxalate, and fluoxetine or SNRIs such as venlafaxine, and duloxetine for depression.
Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.
Taking Rizatriptan with food and drink:
Rizatriptan can take longer to work if it is taken after food. Although it is better to take it on an empty stomach, you can still take it if you have eaten.
Pregnancy and breast-feeding
It is not known whether Rizatriptan is harmful to an unborn baby when taken by a pregnant woman.
Talk to your doctor before taking this medicine if you are pregnant, planning to get pregnant or are breastfeeding. Breastfeeding should be avoided for 24 hours after treatment.
Ask your doctor or pharmacist for advice before taking any medicine.
Use in children
The use of Rizatriptan oral lyophilisates in children under 18 years is not recommended.
Use in patients older than 65 years
There have been no full studies to look at how safe and effective Rizatriptan is amongst patients older than 65 years.
Driving or using machines
You may feel sleepy or dizzy while taking Rizatriptan. If this happens, do not drive or use any tools or machines.
Important information about some of the ingredients of Rizatriptan
Phenylketonuric patients: Contains a source of phenylalanine. May be harmful for people with phenylketonuria. Each Rizatriptan oral lyophilisate contains 3.75 mg of aspartame (which contains phenylalanine).
3. HOW TO TAKE RIZATRIPTAN
Rizatriptan is used to treat migraine attacks. Take Rizatriptan as soon as possible after your migraine headache has started. Do not use it to prevent an attack.
Always take Rizatriptan exactly as your doctor has told you. You should check with your doctor or your pharmacist if you are not sure.
The usual dose is 10 mg.
If you are currently taking propranolol or have kidney or liver problems you should use the 5-mg dose of Rizatriptan. You should leave at least 2 hours between taking propranolol and Rizatriptan up to a maximum of 2 doses in a 24-hour period.
If migraine returns within 24 hours
In some patients, migraine symptoms can return within a 24-hour period. If your migraine does return you can take an additional dose of Rizatriptan. You should always wait at least 2 hours between doses.
If you do not respond to the first dose of Rizatriptan during an attack, you should not take a second dose of Rizatriptan for treatment of the same attack. It is still likely, however, that you will respond to Rizatriptan during the next attack.
Do not take more than 2 doses of Rizatriptan in a 24-hour period, (for example, do not take more than two 10-mg oral lyophilisates or more than two 10 mg or 5 mg tablets in a 24-hour period). You should always wait at least 2 hours between doses.
If your condition worsens, seek medical attention.
How to administer Rizatriptan oral lyophilisates
- Rizatriptan (rizatriptan benzoate) is available as a 10 mg oral lyophilisate that dissolves in the mouth.
- Open the Rizatriptan oral lyophilisate blister pack with dry hands.
- The oral lyophilisate should be placed on your tongue, where it dissolves and can be swallowed with the saliva.
- The oral lyophilisate can be used in situations in which liquids are not available, or to avoid the nausea and vomiting that may accompany the ingestion of tablets with liquids.
Rizatriptan is also available as a tablet to be taken with liquids.
If you take more Rizatriptan than you should:
If you take more Rizatriptan than you should, talk to your doctor or pharmacist straight away. Take the medicine pack with you.
Signs of overdosage can include dizziness, drowsiness, vomiting, fainting and slow heart rate.
If you have any further questions on the use of this product ask your doctor or pharmacist.
4. POSSIBLE SIDE EFFECTS
Like all medicines, Rizatriptan can cause side effects, although not
everybody gets them. The following side effects may happen with
this medicine.
In adult studies, the most common side effects reported were
dizziness, sleepiness and tiredness.
Common (affects 1 to 10 users in 100)
• tingling (paraesthesia), headache, decreased sensitivity of skin (hypoaesthesia), decreased mental sharpness, tremor,
• fast or irregular heart beat (palpitation), very fast heartbeat (tachycardia),
• flushing (redness of the face lasting a short time), hot flushes, sweating,
• throat discomfort, difficulty breathing (dyspnoea),
• feeling sick (nausea), dry mouth, vomiting, diarrhoea,
• feeling of heaviness in parts of the body,
• pain in abdomen or chest,
• rash.
Uncommon (affects 1 to 10 users 1000)
• unsteadiness when walking (ataxia), dizziness (vertigo), blurred vision,
• confusion, insomnia, nervousness,
• high blood pressure (hypertension); thirst, indigestion (dyspepsia),
• itching and lumpy rash (hives), allergic reaction (hypersensitivity; swelling of face, lips, tongue and/or throat which may cause difficulty breathing and/or swallowing (angioedema),
• neck pain, feeling of tightness in parts of the body, stiffness, muscle weakness
Rare (affects 1 to 10 users in 10,000)
• bad taste in your mouth,
• fainting (syncope), a syndrome called “serotonin syndrome” that may cause side effects like coma, unstable blood pressure, extremely high body temperature, lack of muscle co-ordination, agitation, and hallucinations
• facial pain, wheezing
• sudden life-threatening allergic reaction (anaphylaxis), severe shedding of the skin with or without fever (toxic epidermal necrolysis),
• heart attack, spasm of blood vessels of the heart, stroke. They generally occur in patients with risk factors for heart and blood vessel disease (high blood pressure, diabetes, smoking, use of nicotine substitution, family history of heart disease or stroke, man over 40 years of age, post-menopausal women, particular problem with the way your heart beats [bundle branch block]).
Not known (frequency cannot be estimated from the available data):
• seizure (convulsions/fits),
• spasm of blood vessels of the extremities including coldness and numbness of the hands or feet,
• spasm of the blood vessels of the colon (large bowel), which can cause abdominal pain,
• muscle pain,
• changes in the rhythm or rate of the heartbeat (arrhythmia), slow heartbeat (bradycardia), abnormalities of the electrocardiogram (a test that records the electrical activity of your heart).
Tell your doctor right away if you have symptoms of allergic reactions, serotonin syndrome, heart attack or stroke.
In addition, tell your doctor if you experience any symptoms that suggest an allergic reaction (such as a rash or itching) after taking Rizatriptan.
If any of the side effects get serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
5. HOW TO STORE RIZATRIPTAN
• KEEP OUT OF THE SIGHT AND REACH OF CHILDREN.
• Rizatriptan should be not stored above 30°C.
• Do not remove the oral lyophilisate from its blister or the aluminium sachet until you are ready to take it.
• Keep the oral lyophilisate in the carrying case for protection.
• Do not put the oral lyophilisate into another container, as they might get mixed up.
• Do not use after the expiry date printed on the carton label or blister strip.
• If your doctor tells you to stop using the medicine, please take it back to the pharmacist for safe disposal. Only keep the medicine if your doctor tells you to.
• If the medicine becomes discoloured or shows any other signs of deterioration, you should seek the advice of your pharmacist who will tell you what to do.
• Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose medicines no longer required. These measures will help to protect the environment.
6. FURTHER INFORMATION
What Rizatriptan contains
Each lyophilisate contains 14.53mg rizatriptan benzoate equivalent to 10.00mg of rizatriptan
Rizatriptan oral lyophilisate also contain the following inactive ingredients: gelatin, mannitol, glycine, aspartame (E951) and peppermint flavour.
What Rizatriptan looks like and contents of the pack
Rizatriptan is a white to off-white, round, peppermint flavoured oral lyophilisate embossed with a rounded square. Rizatriptan is a freeze-dried oral lyophilisate which dissolves in the mouth.
Rizatriptan is available in packs of 3 individually sealed oral lyophilisate
Product Licence holder
Procured from within the EU and repackaged by the Product Licence holder: S&M Medical Ltd, Chemilines House,
Alperton Lane, Wembley, HA0 1DX.
Manufacturer
These products are manufactured by Catalent UK Swindon Zydis Ltd, Swindon, UK.
|POM | PL No: 19488/0761 Leaflet revision date: 03 August 2012
Further information about migraine is available from the following organisations:
Migraine Action Association 4th Floor, 27 East Street Leicester LE1 6NB
Tel: 0116 275 8317 Fax: 0116 254 2023 and
The Migraine Trust
55-56 Russell Square
London
WC1B 4HP
Tel: 020 7631 6970
Fax: 020 7436 2886
Email: info@migrainetrust.org
Helpline: 020 7462 6601, Monday to Friday 10am - 5pm
S761 LEAFLET Rizatriptan 20120803